Medicare Enrolled
Dr. Sarada Gurubhagavatula, MD
Hematology & Oncology · Florham Park, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gurubhagavatula from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gurubhagavatula?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gurubhagavatula
Dr. Sarada Gurubhagavatula is a hematology & oncology specialist in Florham Park, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gurubhagavatula performed 9,002 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gurubhagavatula received a total of $92,833 from 22 pharmaceutical and/or device companies across 170 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gurubhagavatula is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 34% volume in NJ
$92,833 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗9,002
Medicare services
Top 34% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,142 | $8 | $32 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,139 | $8 | $15 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
893 | $6 | $28 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
889 | $4 | $19 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
886 | $5 | $20 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
882 | $10 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
505 | $150 | $366 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
469 | $6 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
342 | $105 | $274 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
271 | $13 | $56 |
| Iron level test | 269 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
269 | $9 | $36 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
184 | $29 | $121 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
118 | $102 | $256 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
105 | $8 | $38 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
100 | $16 | $69 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
93 | $9 | $37 |
| Basic blood chemical test (calcium, ionized) A blood test that measures basic chemical levels, specifically including calcium and ionized calcium. |
59 | $13 | $35 |
| New patient office visit, complex (60-74 min) | 47 | $180 | $516 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
46 | $15 | $62 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
45 | $14 | $61 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
43 | $147 | $497 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $67 | $179 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
34 | $17 | $52 |
| Liver function blood test panel | 33 | $8 | $34 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
20 | $16 | $67 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
19 | $10 | $40 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
18 | $11 | $36 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
18 | $4 | $17 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
17 | $13 | $55 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
12 | $30 | $169 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$92,833
Total received (2018-2024)
Avg $13,262/year across 7 years
Top 4% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
170
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,572
2023
$8,514
2022
$900
2021
$9,808
2020
$12,942
2019
$13,769
2018
$32,326
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$14,572
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$61,912
Genentech USA, Inc.
$22,845
Takeda Pharmaceuticals U.S.A., Inc.
$2,871
Janssen Biotech, Inc.
$1,609
Lilly USA, LLC
$1,198
Janssen Scientific Affairs, LLC
$1,170
Regeneron Healthcare Solutions, Inc.
$540
Merck Sharp & Dohme Corporation
$128
Puma Biotechnology, Inc.
$116
Astellas Pharma US Inc
$110
Foundation Medicine, Inc.
$44
Seagen Inc.
$44
PFIZER INC.
$44
EISAI INC.
$43
Novartis Pharmaceuticals Corporation
$33
Eisai Inc.
$31
Gilead Sciences, Inc.
$27
Bayer HealthCare Pharmaceuticals Inc.
$15
Pharmacyclics LLC, An AbbVie Company
$15
GENZYME CORPORATION
$15
EUSA Pharma (US) LLC
$13
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 94.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · Alecensa · BOSULIF · CALQUENCE · CYRAMZA · ELITEK · FOUNDATIONONE · IBRANCE · IMBRUVICA · IMFINZI · Imbruvica · KEYTRUDA · KISQALI · LIBTAYO · LYNPARZA · Lenvima · Nerlynx · Non-Covered Product · OPDIVO · ROZLYTREK · RYBREVANT · Sylvant · TAGRISSO · TECENTRIQ · TUKYSA · Tarceva · VERZENIO · Vitrakvi · XOSPATA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
557
County median income
$134,929
Nearest hospital to ZIP centroid (approximate)
COOPERMAN BARNABAS MEDICAL CENTER
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gurubhagavatula is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gurubhagavatula experienced with complete blood count (cbc) with differential?
Based on Medicare claims data, Dr. Gurubhagavatula performed 1,142 complete blood count (cbc) with differential services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gurubhagavatula receive payments from pharmaceutical companies?
Yes. Dr. Gurubhagavatula received a total of $92,833 from 22 companies across 170 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gurubhagavatula's costs compare to other hematology & oncology specialists in Florham Park?
Dr. Gurubhagavatula's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gurubhagavatula) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Florham Park
Browse hematology & oncology specialists in Florham Park ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology